(Q48292008)

English

Clinical relevance of alterations in quantity and quality of plasma DNA in colorectal cancer patients: based on the mutation spectra detected in primary tumors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24841357

Clinical relevance of alterations in quantity and quality of plasma DNA in colorectal cancer patients: based on the mutation spectra detected in primary tumors (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24841357

0 references

colorectal cancer

1 reference

based on heuristic

inferred from title

colorectal carcinoma

1 reference

based on heuristic

inferred from title

author name string

Jen-Kou Lin

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24841357

Pei-Ching Lin

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24841357

Chien-Hsing Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24841357

Jeng-Kai Jiang

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24841357

Shung-Haur Yang

5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24841357

Wen-Yi Liang

6

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24841357

Wei-Shone Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24841357

Shih-Ching Chang

8

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24841357

publication date

20 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24841357

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24841357

21 Suppl 4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24841357

S680-6

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24841357

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Early postoperative CEA level is a better prognostic indicator than is preoperative CEA level in predicting prognosis of patients with curable colorectal cancer.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Cell-free nucleic acids as biomarkers in cancer patients

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Comprehensive molecular characterization of human colon and rectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Quantitative cell-free DNA, KRAS, and BRAF mutations in plasma from patients with metastatic colorectal cancer during treatment with cetuximab and irinotecan.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Plasma DNA as a molecular marker for completeness of resection and recurrent disease in patients with esophageal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Analysis of circulating tumor DNA to monitor metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Shedding microvesicles: artefacts no more

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Flow cytometric analysis of circulating microparticles in plasma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Circulating free tumor DNA and colorectal cancer.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Circulating mutant DNA to assess tumor dynamics

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Mutational analysis and clinical correlation of metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Microsatellite instability and BRAF mutation testing in colorectal cancer prognostication

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

High resolution melting analysis of KRAS, BRAF and PIK3CA in KRAS exon 2 wild-type metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Loss of heterozygosity and DNA aneuploidy in colorectal adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3804-5

21 January 2018

Identifiers

10.1245/S10434-014-3804-5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24841357

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/24841357

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48292008&oldid=2209293305"